BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.73
Market Cap
(Rs In Cr.)
14,725
P/E (TTM)
9.7
EPS (TTM)
84.75
Face Value
(Rs)
2
Back
NATCO Pharma Asia acquires 49% stake in PT NATCO Lotus Farma
30-Jan-26   Hrs IST

NATCO Pharma Asia, a wholly-owned subsidiary (WOS) of Natco Pharma (NATCO) incorporated in Singapore, has acquired 49% of shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia.

NATCO already owns 51% of PT NATCO Lotus Farma. Post this acquisition, NATCO along with its WOS wholly-owns 100% of PT NATCO Lotus Farma.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)